Iris melanomas: Diagnosis and management

International Ophthalmology Clinics

Volumn 37, Issue 4, 1997, Pages 87-100

  Yap Veloso, Maria Imelda R ^a   Simmons, Ruthanne B ^a   Simmons, Richard J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPIRATION BIOPSY; BIOMICROSCOPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FLUORESCENCE ANGIOGRAPHY; GLAUCOMA; HUMAN; IRIDECTOMY; IRIS DISEASE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; HUMANS; IRIS NEOPLASMS; MELANOMA; TREATMENT OUTCOME;

EID: 0031440625     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-199703740-00008     Document Type: Review

References (44)

1. Ashton N. Primary tumours of the iris. Br J Ophthalmol 1964;48:650-668
2. Ashton N, Wybar K. Primary tumours of the iris. Ophthalmologica 1966;151:97-113
3. Heath P. Tumours of the iris: classification and clinical follow-up. Trans Am Ophthalmol Soc 1964;62:51-85
4. Duke JR, Dunn SN. Primary tumors of the iris. Arch Ophthalmol 1958;59:204-214
5. Shields JA. Melanocytic tumors of the iris stroma. In: Shields JA, ed. Diagnosis and management of intraocular tumors. Philadelphia: Saunders, 1992:61-83
6. Marcus DM, Sahel JA, Jakobiec FA, Albert DM. Pigmented tumors of the iris. In: Jakobiec FA, Albert DM, eds. Principles and practice of ophthalmology. Philadelphia: Saunders, 1994:3198-3208
7. Ronnes B, Zimmerman LE. The prognosis of primary tumors of the iris treated by iridectomy. Arch Ophthalmol 1958;60:193-205
8. Shields JA. Melanocytic tumors of the iris. In: Shields JA, ed. Diagnosis and management of intraocular tumors. St Louis: Mosby, 1983:83-121
9. Char DH. Clinical ocular oncology. New York: Churchill Livingstone, 1989:151-165
10. Raivio I. Uvea melanoma in Finland: an epidemiological, clinical, histological and prognostic study. Acta Ophthalmol (Copenh) 1977;55:5-64
11. Arentsen JJ, Green WR. Melanoma of the iris: report of 72 cases treated surgically. Ophthalmic Surg 1975;6:23-37
12. Rootman J, Gallagher MA. Color as a risk factor in iris melanoma. Am J Ophthalmol 1984;98:558-561
13. Cialdini AP, Sahel JA, Jalkh AE, et al. Malignant transformation of an ins melanocytoma. Graefes Arch Clin Exp Ophthalmol 1989;227:348-354
14. Johnson MW, Skuta GL, Kincaid MC, et al. Malignant melanoma of the iris in xeroderma pigmentosum. Arch Ophthalmol 1989;107:402-407
15. Reese AB, Mund ML, Iwamoto T. Tapioca melanoma of the iris: I. Clinical and light microscopy studies. Arch Ophthalmol 1972;74:840-850
16. Jakobiec FA, Silbert G. Are most iris "melanomas" really nevi? A clinicopathologic study of 189 lesions. Arch Ophthalmol 1981;99:2117-2132
17. Davidorf FH. The melanoma controversy: a comparison of choroidal, cutaneous, and iris melanomas. Surv Ophthalmol 1981;25:373-377
18. Geisse LJ, Robertson DM. Iris melanomas. Am J Ophthalmol 1985;99:638-648
19. Sunba MSAN, Rahi AHS, Morgan G. Tumors of the anterior uvea: I. Metastasizing malignant melanoma of the iris. Arch Ophthalmol 1989;98:82-85
20. Kurz GH, Zimmerman LE. Spontaneous hyphema and acute glaucoma as initial signs of recurrent iris melanoma. Arch Ophthalmol 1963;69:81-82
21. Shah PG, Shields CL, Shields JA, et al. Band keratopathy secondary to iris melanoma. Cornea 1991;10:67-69
22. Territo C, Shields CL, Shields JA, et al. Natural course of melanocytic tumors of the iris. Ophthalmology 1988;95:1251-1255
23. Harbour JW, Augsburger JJ, Eagle RC, Jr. Initial management and follow up of melanocytic iris tumors. Ophthalmology 1995;102:1987-1993
24. Grossniklaus HE, Oakman JH, Cohen C, et al. Histopathology, morphometry and nuclear DNA content of iris melanocytic lesions. Invest Ophthalmol Vis Sci 1995;36: 745-750
25. Planten JT. An unnecessary mistake. Ophthalmologica 1970;160:369-371
26. Grossniklaus HE, Brown RH, Stulting RD, Blasberg RD. Iris melanoma seeding through a trabeculectomy site. Arch Ophthalmol 1990;108:1287-1290
27. Brovkina AF, Chichua AG. Value of flourescein iridography in diagnosis of tumors of the iridociliary zone. Br J Ophthalmol 1979;63:157-160
28. Demeler U. Fluorescence angiographical studies in the diagnosis and follow-up of tumors of the iris and ciliary body. Adv Ophthalmol 1981;42:1-17
29. Jakobiec FA, Depot MJ, Shields CL, et al. Fluorescein angiographic patterns of iris melanocytic tumors. Arch Ophthalmol 1982;100:1288-1299
30. Pavlin CJ, Harascrewicz K, Sherar MD, Foster FS. Clinical use of ultrasound biomicroscopy. Ophthalmology 1991;98:287-295
31. Pavlin CJ, McWhae JA, McGowan HD, Foster FS. Ultrasound biomicroscopy of anterior segment tumors. Ophthalmology 1992;99:1220-1228
32. Iezzi R, Rosen RB, Tello C, et al. Personal computer-based three-dimensional ultrasound biomicroscopy of the anterior segment. Arch Ophthalmol 1996;114:520-524
33. Katz NR, Finger PT, McCormick SA, et al. Ultrasound biomicroscopy in the management of malignant melanoma of the iris. Arch Ophthalmol 1995;113:1462-1463
34. Shields JA, Shields CL, Ehya H, et al. Fine needle aspiration biopsy for suspected intraocular tumors. The 1992 Urwick lecture. Ophthalmology 1993;100:1677-1684
35. Shields MB, Klintworth GK. Anterior meal melanomas and intraocular pressure. Ophthalmology 1980;87:503-517
36. Yanoff M. Glaucoma mechanisms in ocular malignant melanomas. Am J Ophthalmol 1970;70:898-904
37. Grossniklaus HE. Fine needle aspiration biopsy of the iris. Arch Ophthalmol 1992;110: 969-976
38. Glasgow BJ, Brown HH, Zargoza AM, Foos RY. Quantitation of tumor seeding from fine needle aspiration biopsy of ocular melanomas. Am J Ophthalmol 1988;105:538-546
39. Midena E, Seagate T, Piermarocchi S, Boccato P. Fine needle aspiration biopsy in ophthalmology. Surv Ophthalmol 1985;29:410-422
40. Char DH, Crawford JB, Kroll S. Iris melanomas. Diagnostic problems. Ophthalmology 1996;103:251-255
41. Shields JA, Shields CL, Donoso LA. Management of posterior uveal melanoma. Surv Ophthalmol 1991;34:161-195
42. Shields CL, Shields JA, De Potter P, et al. Treatment of non-resectable malignant iris tumors with custom designed plaque radiotherapy. Br J Ophthalmol 1995;79:306-312
43. Mackley TA. The management of malignant melanomas of the anterior segment. Surv Ophthalmol 1974;19:135-153
44. Forrest AW, Keyser RB, Spencer WH. Iridocyclectomy for melanomas of the ciliary body: a follow-up study of pathology and surgical morbidity. Ophthalmology 1978;85: 1237-1239